In conclusion, we have developed a clinically applicable assay for sensitive detection of EZH2 codon 641 mutations in FFPE tissue, and demonstrate frequent occurrence of these gain-of-function mutations in the full biological spectrum of BCL2-rearranged germinal center phenotype B cell lymphomas, but not in Burkitt lymphoma. Here, BCL2 is linked to Burkitt lymphoma.